NOVAVAX INC (NVAX) Form 10-K Annual Reports
NOVAVAX INC (NVAX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NVAX
CIK: 1000694
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerJason Frederick
Audit LocationTysons, Virginia, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-10-16 | — | SCHEDULE 13G Filing | 0001398344-26-018328 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-10-16 | — | SCHEDULE 13D/A Filing | 0001398344-26-018323 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000510 | View SEC Doc Filr Page |
| S-8 | 2026-08-06 | — | FORM S-8 | 0001104659-26-091965 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001000694-26-000019 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001000694-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | OWNERSHIP DOCUMENT | 0001104659-26-076930 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | OWNERSHIP DOCUMENT | 0001104659-26-076928 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | OWNERSHIP DOCUMENT | 0001104659-26-076927 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | OWNERSHIP DOCUMENT | 0001104659-26-076926 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | OWNERSHIP DOCUMENT | 0001104659-26-076925 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | OWNERSHIP DOCUMENT | 0001104659-26-076924 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | OWNERSHIP DOCUMENT | 0001104659-26-076923 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | OWNERSHIP DOCUMENT | 0001104659-26-076922 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-18 | FORM 8-K | 0001104659-26-076648 | View SEC Doc Filr Page |
| 144 | 2026-05-27 | — | 144 Filing | 0001628280-26-038512 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-05-15 | — | SCHEDULE 13D/A Filing | 0001398344-26-009210 | View SEC Doc Filr Page |
| 144 | 2026-05-07 | — | 144 Filing | 0001628280-26-032295 | View SEC Doc Filr Page |
| 8-K | 2026-05-06 | 2026-05-06 | 8-K | 0001628280-26-030924 | View SEC Doc Filr Page |
| 10-Q | 2026-05-06 | 2026-03-31 | 10-Q | 0001628280-26-030917 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-30 | — | SCHEDULE 13G Filing | 0002100119-26-000933 | View SEC Doc Filr Page |
| 4 | 2026-04-28 | 2026-04-25 | OWNERSHIP DOCUMENT | 0001104659-26-050457 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-04-27 | — | SCHEDULE 13G/A Filing | 0000070858-26-000241 | View SEC Doc Filr Page |
| ARS | 2026-04-27 | 2025-12-31 | ARS | 0001104659-26-049137 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-27 | — | DEFA14A | 0001628280-26-027330 | View SEC Doc Filr Page |